Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
USD Bond Movement | Shimao Group SHIMAO 2 07/21/32 price fell 57.45% to 0.520.
16/09/2026
On September 16, SHIMAO 2 07/21/32 issued by Shimao Group was priced at 0.520, down -57.450%, with a yield of 104.336%.
Latest
1 m ago
SSY Group (02005.HK) repurchased 850,000 shares for HK$2.304 million on September 16.
3 m ago
Fibocom (00638.HK) repurchased 682,800 A shares for RMB 7.0482 million on September 16.
4 m ago
Sanofi (SNY.O) unveiled its Shanghai Foreign-Funded R&D Innovation Center, and signed a cooperation agreement with Huashan Hospital Affiliated to Fudan University for a "Center of Excellence in Translational Research." In 2025, Sanofi's revenue reached 46.7 billion euros, with China being Sanofi's second-largest market globally. According to the plan, the center will become Sanofi's largest translational medicine research center in China, bringing together global R&D forces to advance innovative drug development in key areas such as immunology, chronic diseases, oncology, and rare diseases. (Yicai)
8 m ago
SBT Ultrasonic Technology (688392.SH)'s application for issuing A-shares to specific targets received approval for registration from the CSRC.
10 m ago
Deye Co., Ltd. (605117.SH) plans to repurchase company shares for RMB 100 million to RMB 200 million.
See all latest